Longeveron (LGVN) Return on Sales (2020 - 2026)

Longeveron (LGVN) recorded quarterly Return on Sales of 0.12% in Q1 2026, up 18.89% quarter-over-quarter from 0.15% in Q4 2025, and up 2.0% on a YoY basis from 0.12% in Q1 2025.

Longeveron (LGVN) Return on Sales (2020 - 2026) Analysis & Trends

Longeveron's Return on Sales history runs 7 years deep, the most recent figure standing at 0.12% for Q1 2026.

  • In Q1 2026, Return on Sales rose 2.0% year-over-year to 0.12%; the TTM figure through Mar 2026 stood at 0.19% (down 11.0% YoY), while the FY2025 annual figure was 0.19%, down 13.0% from the prior year.
  • Return on Sales was 0.12% for Q1 2026 at Longeveron, up from 0.15% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.06% in Q3 2024 to a low of 0.86% in Q4 2023.
  • Historically, Return on Sales has averaged 0.25% across 5 years, with a median of 0.15% in 2025.
  • The sharpest annual moves came in 2024 and 2025: Return on Sales jumped 79 bps in 2024, then tumbled 47 bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.55% in 2022, then tumbled by 57 bps to 0.86% in 2023, then jumped by 92 bps to 0.07% in 2024, then plunged by 108 bps to 0.15% in 2025, then climbed by 19 bps to 0.12% in 2026.
  • The last three Return on Sales figures came in at 0.12% (Q1 2026), 0.15% (Q4 2025), and 0.53% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.00%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 0.00%
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.00%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 -0.12%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.12%
Dec 31, 2025 -0.15%
Sep 30, 2025 -0.53%
Jun 30, 2025 -0.17%
Mar 31, 2025 -0.14%
Dec 31, 2024 -0.07%
Sep 30, 2024 -0.06%
Jun 30, 2024 -0.07%
Mar 31, 2024 -0.07%
Dec 31, 2023 -0.86%
Sep 30, 2023 -0.34%
Jun 30, 2023 -0.26%
Mar 31, 2023 -0.17%
Dec 31, 2022 -0.55%
Sep 30, 2022 -0.52%
Jun 30, 2022 -0.09%
Mar 31, 2022 -0.09%
Dec 31, 2021 -0.19%
Sep 30, 2021 -0.21%
Jun 30, 2021 -0.10%